1st Apr 2025 09:30
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 April 2025
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of schemes: | Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") | |||
Period of return | From: | 1 October 2024 | To: | 31 March 2025 |
Balance of unallotted securities under scheme(s) from previous return: | 311,430 Ordinary Shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 Ordinary Shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 Ordinary Shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 311,430 Ordinary Shares of 10 pence |
Name of contact: | Helen Middlemist |
Telephone number of contact: | +44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)
Related Shares:
Hikma Pharmaceuticals